VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 12, 2007) - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection CompanyTM, announced today that it has been granted a US patent covering additional composition of matter for the products in the ADNP platform, which broadens the intellectual property of Allon’s patent portfolio.
